EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair
EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair
Read moreWed, 06th Oct 2021 09:26
EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair
Read moreIN BRIEF: Ceres Power strikes deal with IP Group investee RFC
Read more(Sharecast News) - Intellectual property company IP Group said on Thursday that portfolio company RFC Power, a long-duration energy storage company, had signed a joint development agreement with fuel cell technology firm Ceres Power.
Read moreIN BRIEF: IP Group investee Hinge Health valued at over USD6 billion
Read moreIN BRIEF: IP Group books GBP27.5 million fair value gain
Read more(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that, following the completion of a funding round by a portfolio company in its top 20 most valuable holdings, it recorded a net realised and unrealised fair value gain of about £27.5m, or 2.6p per share.
Read moreOxford BioMedica licences technology for cystic fibrosis treatment
Read more(Sharecast News) - Gene and cell therapy firm Oxford Biomedica said on Tuesday that pharmaceutical giant Boehringer Ingelheim had exercised its option to license its lentiviral vector technology to manufacture, register and commercialise a treatment for cystic fibrosis.
Read moreIN BRIEF: Outgoing IP Group CEO Alan Aubrey buys 40,000 shares
Read moreLONDON MARKET MIDDAY: Shares fall as gas prices fuel inflation fear
Read moreTOP NEWS: Oxford Nanopore IPO prompts change at top at IP Group
Read moreLONDON MARKET MIDDAY: Stocks mixed; Oxford Nanopore soars on debut
Read moreUPDATE: Oxford Nanopore nears GBP5 billion value in London debut
Read more(Sharecast News) - Shares in Oxford Nanopore Technologies surged on Thursday after the British biotech made its £3.4bn debut on the London Stock Exchange.
Read more